← Leaderboards
Nicholas Schafer
Constantiam Biosciences Inc.
$2,986,115
Attributed
$2,986,115
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.5M · FY2022–25$2M$1.5M$1M$500K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$2,986,115 · 3
By mechanism
R44$2,046,556 · 1
R43$939,559 · 2
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Malignant Neoplasms”
- David Annett · Information Management Services, Inc.$35,571,865
- Michael Difilippantonio · Leidos Biomedical Research, Inc.$22,364,766
- Jon White · Midwest Research Institute$17,594,074
- Carolina Porras · Fundacion Inciensa$10,814,023
- Alanna Maguire · Mayo Clinic Rochester$9,942,431
- Hill Georgette · Integrated Laboratory Systems, Llc$8,700,000
Research focus
Malignant NeoplasmsGenetic TestingClassificationMultiplex AssayInnovationVariantPhysiciansVariant Of Unknown SignificanceLaboratoriesMedicalGenesBiological SciencesExperimental StudyData SetAlzheimer&AposGenetic VariantBayesian AnalysisProgramsDiagnosisClinvarPrototypeDecision MakingAreaBrca1 Gene
Grant awards (5)
Platform to support clinical variant interpretation through probabilistic assessment of functional evidence$1,030,156
R44 · FY2025 · HG · contact PI
Platform to support clinical variant interpretation through probabilistic assessment of functional evidence$1,016,400
R44 · FY2024 · HG · contact PI
Leveraging high-throughput functional data for assessment of Alzheimer's risk$485,192
R43 · FY2024 · AG · contact PI
Platform to support clinical variant interpretation through probabilistic assessment of functional evidence$55,000
R43 · FY2023 · HG · contact PI
Platform to support clinical variant interpretation through probabilistic assessment of functional evidence$399,367
R43 · FY2022 · HG · contact PI